<DOC>
	<DOCNO>NCT00046345</DOCNO>
	<brief_summary>The purpose clinical research study provide atazanavir patient infected human immunodeficiency virus ( HIV ) whose antiviral medication longer work control HIV activity within body unable create new treatment regimen use available anti-HIV drug , either side effect treatment failure previously take . The safety treatment also study .</brief_summary>
	<brief_title>Atazanavir HIV Infected Individuals : An Early Access Program</brief_title>
	<detailed_description />
	<mesh_term>HIV Infections</mesh_term>
	<mesh_term>Atazanavir Sulfate</mesh_term>
	<criteria>Key inclusion criterion : Patients eligible inclusion EAP virologic failure due resistance , intolerance and/or adherence problem current antiHIV medication ; OR multiple toxicity intolerance antiHIV medication virologic failure ; OR severe elevate lipid blood ( e.g. , cholesterol , triglyceride ) respond lipidlowering medication . Key exclusion Criteria : Restrictions apply regard use atazanavir specific medication may potential cause possible side effect take together . Patients also exclude follow reason : 1 ) pregnancy breast feeding , 2 ) elevate liver enzyme , 3 ) significant cardiovascular disease , 4 ) restriction indicate protocol .</criteria>
	<gender>All</gender>
	<minimum_age>16 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2011</verification_date>
	<keyword>treatment experience</keyword>
</DOC>